SELENBP1 and colonic neoplasm: After proving in vitro and in vivo in melanoma tumor models that PLGA-siCD47-MTO can be efficiently up taken by tumor cells with the consequent reduction of tumor growth, the authors investigated a xenograft mouse model of colon cancer employing the colon cancer cells CT26.